Glen Rock, N.J., February 4, 2016/Globe Newswire – RespireRx Pharmaceuticals Inc. (OTC QB: RSPI) (“RespireRx” or the “Company”), a leader in the developent of medicines for respiratory disorders, including sleep apneas and drug-induced respiratory depression, announces that the Company’s President & CEO and Vice Chairman of the Board of Directors, James S. Manuso, Ph.D., will…
RespireRx Expands Research Initiatives Involving Treatments for Drugs of Abuse Glen Rock, N.J., January 19, 2016/Globe Newswire – RespireRx Pharmaceuticals Inc. (OTC: RSPI) (“RespireRx” or the “Company”) announces that the Company has reached an agreement with the Medications Development Program of the National Institute of Drug Abuse (“NIDA”) for NIDA to conduct research on RespireRx…
Glen Rock, N.J., January 19, 2016/Globe Newswire – RespireRx Pharmaceuticals Inc. (OTC QB: RSPI) (“RespireRx” or the “Company”), a leader in developing drugs for respiratory disorders, particularly sleep apneas and drug-induced respiratory depression, announces that the Company’s Vice President, Treasurer and Secretary and member of the Board of Directors, Jeff Margolis will present at the…
CEO to Review Initiatives in the Treatment of Respiratory Disorders and Provide Pipeline Update RespireRx Announces Ticker Symbol Change Glen Rock, N.J., Jan. 11, 2016/Globe Newswire – RespireRx Pharmaceuticals Inc. (OTC QB: RSPI as of January 11, 2016; previously OTC QB: CORX) (“RespireRx” or the “Company”), a leader in developing drugs for respiratory disorders, particularly…
Cortex CEO James S. J. Manuso, Ph.D. to Present Glen Rock, N.J., October 19, 2015/Globe Newswire – Cortex Pharmaceuticals, Inc. (OTC: CORX) (“Cortex” or the “Company”), a leader in developing drugs for respiratory disorders, particularly obstructive and central sleep apneas and drug-induced respiratory depression, announces that it will be presenting at the 14th Annual BIO…
James S. J. Manuso, Ph.D., New Cortex CEO, to Present GLEN ROCK, NJ — September 8, 2015/Globe Newswire – Cortex Pharmaceuticals, Inc. (OTC: CORX) (“Cortex” or the “Company”), a leader in developing drugs for respiratory disorders, particularly obstructive sleep and central apneas and drug-induced respiratory depression, announces that it will be presenting at the Rodman &…
Dr. Arnold S. Lippa, Ph.D., to Continue as Executive Chairman of the Board of Directors and Chief Scientific Officer GLEN ROCK, NJ – (Marketwired – Aug 19, 2015) – Cortex Pharmaceuticals, Inc. (OTCQB: CORX) (“Cortex” or the “Company”), a leader in the discovery and development of innovative pharmaceuticals for the treatment of breathing disorders, today…